Sartorius Stedim Biotech SA 2022 IR
The report outlines Sartorius Stedim Biotech's performance in fiscal year 2022, during which sales revenue rose 15.1% in constant currencies to approximately 3.5 billion euros. The company continued to invest heavily in expanding production capacities globally, with capital expenditures reaching 430.6 million euros. It also completed two key acquisitions, Novasep's chromatography division and Albumedix, to strengthen its bioprocessing portfolio. Although the company is exempt from publishing a detailed non-financial statement as its sustainability information is included in the report of its parent company, Sartorius AG, it has integrated non-financial KPIs, such as reducing CO2 emission intensity, into its executive compensation structure.
Company: Sartorius Stedim Biotech SA
Sector: Health Care
Country: France
Year: 2022
Type: IR
Pages: 252
Sartorius Stedim Biotech SA
Universal Registration Document
The report outlines Sartorius Stedim Biotech's performance in fiscal year 2022, during which sales revenue rose 15.1% in constant currencies to approximately 3.5 billion euros. The company continued to invest heavily in expanding production capacities globally, with capital expenditures reaching 430.6 million euros. It also completed two key acquisitions, Novasep's chromatography division and Albumedix, to strengthen its bioprocessing portfolio. Although the company is exempt from publishing a detailed non-financial statement as its sustainability information is included in the report of its parent company, Sartorius AG, it has integrated non-financial KPIs, such as reducing CO2 emission intensity, into its executive compensation structure.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2022
Reporting Period
Jan 1, 2022 - Dec 31, 2022
Fiscal Year
2022
Published
Feb 16, 2023
Type
Integrated Report
Language
English
Pages
File Size
Standards & Assurance
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Women on Board
Women in Management
Employees